(Q36680831)

15 August 2017

1 reference

title

Hepatic resection in the treatment of hilar cholangiocarcinoma (English)

1 reference

15 August 2017

0 references

David M Nagorney

1

1 reference

PubMed ID

17163100

15 August 2017

Michael L Kendrick

series ordinal

2

1 reference

15 August 2017

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

40

1 reference

15 August 2017

159-171

1 reference

15 August 2017

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Sclerosing carcinoma of the major intrahepatic bile ducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

CONGENITAL HEMOLYTIC JAUNDICE CORRECTED BY SPLENECTOMY FOLLOWED TWENTY-SIX YEARS LATER BY BLEEDING TENDENCY, HEPATOMEGALY AND SUDDEN DEATH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

7 January 2021

Biliary tract cancers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Pathological aspects of cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Invasive growth patterns of hepatic hilar ductal carcinoma. A histologic analysis of 18 surgical cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Management Strategies in Resection for Hilar Cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Multidisciplinary management of perihilar bile duct cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Portal vein evaluation with US: comparison to angiography combined with CT arterial portography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Outcome of extended right hepatectomy after biliary drainage in hilar bile duct cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Portal vein embolization: rationale, technique and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Hepatic resection in the treatment of perihilar cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Combined portal vein and liver resection for carcinoma of the biliary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Actual long-term outcome of extrahepatic bile duct cancer after surgical resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Extended resections for hilar cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Surgery for hilar cholangiocarcinoma: an Italian experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

One hundred and eleven liver resections for hilar bile duct cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Surgical treatment for hilar cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma: a report of 42 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Surgical management of hilar cholangiocarcinoma: the Nagoya experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Surgical management of hilar cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Management of Proximal cholangiocarcinomas by surgical resection and radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Liver transplantation for cholangiocarcinoma: results in 207 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Liver transplantation for unresectable perihilar cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

The role of liver transplantation in the treatment of hilar cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Radiation therapy, chemotherapy and chemoradiation in hilar cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2006.05.009

10.1016/J.YASU.2006.05.009

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17163100